LECAP Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,086
Closed -$2.2M 306
2025
Q4
$2.2M Buy
+33,086
New +$2.14M 0.87% 10
2025
Q3
Sell
-21,528
Closed -$1.88M 310
2025
Q2
$1.88M Sell
21,528
-35,344
-62% -$2.77M 0.66% 38
2025
Q1
$3.88M Buy
56,872
+31,525
+124% +$2.57M 0.91% 8
2024
Q4
$1.97M Sell
25,347
-22,196
-47% -$1.64M 0.53% 61
2024
Q3
$3.19M Buy
47,543
+22,623
+91% +$1.86M 0.69% 34
2024
Q2
$2.83M Buy
+24,920
New +$3.15M 0.61% 43

Other funds holding DXCM

LECAP Asset Management's DXCM Position: Q1 2026 in Review

LECAP Asset Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 33,086 shares — an estimated $2.2M sold.

LECAP Asset Management first reported a position in DXCM in Q2 2024 and held it in 6 quarters. The position peaked at $3.88M in Q1 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • LECAP Asset Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • LECAP Asset Management sold 33,086 DexCom shares in Q1 2026, an estimated $2.2M.
  • LECAP Asset Management first reported a position in DexCom in Q2 2024 and held it in 6 quarters.
  • LECAP Asset Management's DexCom position peaked at $3.88M in Q1 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.